Welcome to our dedicated page for Sharps Technology SEC filings (Ticker: STSSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sharps Technology Inc. (STSSW) SEC filings page aggregates regulatory documents for Sharps Technology, Inc., a Nevada corporation whose common stock trades on Nasdaq under the symbol STSS. These filings provide detailed insight into the company’s medical device and pharmaceutical packaging activities, its Solana-focused digital asset treasury strategy, and the capital markets transactions that support both areas. Investors analyzing STSSW, which represents warrants linked to Sharps Technology’s common stock, can use these filings to understand the underlying corporate structure and key contractual arrangements.
Form 8-K current reports disclosed by the company describe material definitive agreements, including securities purchase agreements for private placements of common stock, pre-funded warrants, and stapled warrants. These documents explain how Sharps Technology raised funds to acquire SOL, the native asset of the Solana blockchain, and to establish Solana treasury operations, as well as the terms of registration rights agreements, warrant amendments, and at-the-market offering arrangements. Additional 8-K disclosures outline strategic advisor and consulting agreements connected to the company’s crypto technology and treasury activities.
Definitive proxy statements on Schedule 14A (DEF 14A) offer further context on governance and shareholder approvals. These filings cover items such as the election of directors, approval of equity incentive plans, increases in authorized common stock, and special meeting proposals to approve share issuances upon exercise of pre-funded and stapled warrants, including those associated with cryptocurrency-related financings and strategic advisor warrants. Together, these materials document how Sharps Technology structures and seeks stockholder approval for key elements of its financing and treasury strategy.
On this page, users can access these SEC filings as they become available through EDGAR, and can use AI-powered tools to summarize complex documents such as proxy statements and current reports. This helps readers quickly identify provisions related to warrant terms, share issuance approvals, treasury strategy disclosures, and advisory and consulting arrangements that are relevant when evaluating Sharps Technology and securities tied to it, such as STSSW.
Sharps Technology, Inc. appointed Arthur Levine as interim Chief Financial Officer under a fee agreement with DLA, LLC. His initial term is three months starting
Levine is an experienced financial executive who has held CFO roles at public companies in healthcare and energy-related services and is a Certified Public Accountant. He has also signed the company’s standard indemnification agreement. Executive Chairman Paul Danner will serve as Principal Financial Officer while the company conducts its search for a permanent CFO.
Sharps Technology, Inc. now has a significant new shareholder group led by FalconX affiliates. FalconX Holdings Limited may be deemed to beneficially own 6,563,498 shares of common stock, or about 16.5% of the company, including shares issuable from stapled warrants that are exercisable within 60 days based on 33,363,003 shares outstanding as of January 20, 2026.
Subsidiaries Solios, Inc. and FalconX Alpha, Inc. each may be deemed to beneficially own 5,794,268 shares, or roughly 14.9%. MNNC-related funds and entities together hold smaller positions primarily through cash stapled warrants. On January 9, 2026, Solios acquired 461,538 shares through a cashless exercise of cash pre-funded warrants, while MNNC Master Fund and MNNC BTC Master Fund sold shares in open-market trades at prices around $1.93 to $1.97 per share.
The investor group states the securities were acquired for investment and to gain exposure to Sharps Technology’s business and growth prospects. They are already in discussions with management and the board regarding strategy, governance, and potential changes to the board and business approach, though they do not currently commit to specific transactional plans.
Sharps Technology major holder FalconX Holdings Limited and affiliated entities reported significant share activity. MNNC Capital Digital Asset Opportunities Master Fund LP and MNNC Capital Digital Opportunities BTC Master Fund LP sold a combined 769,320 shares of common stock on January 9 and 12, 2026 at prices around $1.93–$1.97 per share, reducing their indirect holdings in these funds to zero. On January 9, 2026, Solios, Inc., an affiliate of FalconX, exercised 461,538 cash pre-funded warrants with a $0.0001 exercise price into the same number of Sharps Technology common shares. The footnotes state that FalconX and its intermediate entities disclaim beneficial ownership except to the extent of their pecuniary interests.
Sharps Technology, Inc. (STSS) received a large investment from FalconX‑affiliated entities through an August 2025 private placement, and this Schedule 13D discloses their resulting ownership. FalconX Holdings Limited and related vehicles may be deemed to beneficially own about 20.0% of Sharps’ common stock, based on 28,226,153 shares outstanding.
Key investor Solios, Inc. holds warrants deemed to represent about 15.9% beneficial ownership, while MNNC funds hold smaller stakes of 3.2% and 2.2%. The group invested approximately $45.7 million in cash and digital assets, receiving shares plus multiple series of cash and cryptocurrency-funded warrants, some with a 9.99% beneficial ownership cap. The securities were acquired for investment, with no specific change‑of‑control or restructuring plans disclosed.
FalconX-affiliated entities reported significant holdings in Sharps Technology Inc. common stock and warrants on an initial Form 3. MNNC Capital Digital Asset Opportunities Master Fund LP holds 461,538 common shares and MNNC Capital Digital Opportunities BTC Master Fund LP holds 307,692 shares, both indirectly.
Through Solios, Inc., the group also indirectly holds cash and cryptocurrency stapled warrants and pre-funded warrants exercisable into Sharps common stock, including 4,871,192 shares underlying cryptocurrency stapled warrants at an exercise price of $9.75 and 4,871,192 shares underlying cryptocurrency pre-funded warrants at $0.0001, with the pre-funded warrants having no expiration date.
Sharps Technology, Inc. received a Schedule 13G from Bastion Trading Limited, Bastion Holdings Limited, and Wei Zhu reporting passive ownership of common stock. The Reporting Persons collectively report beneficial ownership of 3,615,046 shares of common stock, representing a 9.99% stake in the company. Due to EDGAR field limits, this percentage is shown as 9.9% on the cover pages.
Bastion Trading directly holds 1,428,394 common shares, as well as pre-funded warrants for up to 4,234,615 shares and additional warrants for up to 5,384,615 shares. These warrants are subject to a beneficial ownership blocker that prevents exercises which would push ownership above 9.99% of outstanding common stock. The ownership percentage is based on an estimated 34,000,000 shares outstanding plus 2,186,652 shares issuable upon warrant exercise within 60 days. The Reporting Persons certify the holdings are not for the purpose of changing or influencing control of Sharps Technology.
Sharps Technology, Inc. received an updated ownership report showing that funds advised by Saba Capital Management, together with related entities and Boaz R. Weinstein, beneficially own 3,050,450 shares of common stock and warrants, representing 9.99% of the class. The percentage is calculated using 28,995,402 shares outstanding as of December 15, 2025 plus 1,538,462 shares issuable upon exercise of certain warrants held by the reporting persons, as referenced in a recent prospectus.
The reporting group states that the securities are not held for the purpose or effect of changing or influencing control of Sharps Technology and are not part of any control-related transaction, other than activities solely in connection with a board nomination process allowed under relevant rules. Dividends and sale proceeds from these securities are payable to the funds and accounts advised by Saba Capital.
Saba Capital Management, L.P., a more than 10% owner of Sharps Technology Inc. (STSS), reported selling common stock in two transactions. On January 15, 2026, it sold 25,000 shares at $2.30 per share. On January 16, 2026, it sold an additional 12,182 shares at $2.37 per share.
After these sales, Saba Capital Management, L.P. beneficially owned 1,511,988 shares of Sharps Technology common stock, held indirectly. The filing notes that, as a result of the January 16, 2026 disposition, the reporting person now owns less than 10% of the issuer’s outstanding shares.
Sharps Technology, Inc. filed a Definitive Proxy Statement asking shareholders to vote on four proposals at a special meeting, principally the approval to issue up to 49,673,120 shares of common stock upon exercise of outstanding Cryptocurrency Warrants and a separate approval for issuance upon exercise of Strategic Advisor Warrants. The filing lists board nominees and executive officers, including Paul K. Danner as Executive Chairman and Principal Executive Officer and Andrew R. Crescenzo as CFO. The statement notes the threshold rule that an issuance equaling or exceeding 20% of outstanding common stock requires shareholder approval. Specific beneficial ownership lines are summarized with individual directors and officers holding less than 1% each.
Sharps Technology Inc. filed a preliminary proxy statement for a special meeting addressing several proposals. Shareholders are asked to elect Annemarie Tierney as a director to serve until the 2026 annual meeting. The company seeks approval under Nasdaq Listing Rule 5635(a) to issue unspecified numbers of common shares upon the exercise of multiple warrant arrangements, including "Cryptocurrency Warrants," "Strategic Advisor Warrants," pre-funded warrants and stapled warrants; the exact share amounts are redacted or shown as placeholders. Other agenda items include adjournment and transacting other proper business at the special meeting. The filing lists named officers and directors including Paul K. Danner (Executive Chairman and Principal Executive Officer), Andrew R. Crescenzo (CFO), and Yuwen (Alice) Zhang (Chief Investment Officer and Director). Several sections and numeric details appear incomplete or redacted in the provided excerpt.